訂閱電子報

首頁 > 最新消息 > 活動訊息 > ITRI-SNBL Joint Seminar-Service and core technolog.... 新聞搜尋:
ITRI-SNBL Joint Seminar-Service and core technology of drug development 活動訊息 2019-11-01
Industrial Technology Research Institute (ITRI)-Shin Nippon Biomedical Laboratories (SNBL)
Joint Seminar Service and core technology of drug development
 
工研院於新藥開發深耕多年,具有完整新藥開發研發能量及服務,可與產
業合作加速國內新藥研發。希藉此研討會分享工研院生醫所藥物發展研發能
量,及產業前臨床試驗之能量,同時討論其他藥物開發之新觀點。期對從事藥
物開發同業在工作上有所助益,及未來有更多合作機會。誠摯邀請您參加。(請查附件會議議程)
 
指導單位:經濟部技術處
主辦單位:工研院生醫所/小分子藥物開發產業聯盟/Shin Nippon Biomedical Laboratories, Ltd. (SNBL)
時 間:108 年 12 月 04 日 (星期三 8:30 am -17:30 pm)
地 點:工研院 光復院區 1 館 802 室/Meeting Room: Kuang Fu-01-802
 (新竹市光復路二段 321 號/321, Sec. 2, Kuang Fu Rd., Hsinchu, Taiwan)
 (地圖連結 https://drive.google.com/file/d/1PzPGivFTNUA2vaDGVLD73_UtNJc7skOK/view)
費 用:免費
 
報名網址
https://wlsms.itri.org.tw/ClientSignUp/Index.aspx?ActGUID=5401A93827
 

報名期間:108/10/29(二) ~ 108/12/1(日) 

 

Agenda

Time

Topic

Speaker

8:30-9:00

Registration

 

9:00-9:10

Opening Remarks

Representative from Industrial Technology Research Institute (ITRI)

9:10-10:00

Introduction of service and core technology of drug development

-New drug development

-Micro-reactor technology

Dr. James Sheu, Division Director, ITRI

10:00-10:30

Break

10:30-11:50

Safety assessment for the development of biologics and other advanced therapy products

Dr. Hideshi Tsusaki, President of Preclinical Service, SNBL

11:50-13:00

Lunch

13:00-14:20

Game Changer in Glaucoma

- Drug development for the treatment of glaucoma with a new mechanism of action

Masahiro Fuwa,

Glaucoma researcher, Pharmacology Group, Santen Pharmaceutical Co., Ltd.

14: 20-15:40

Ophthalmological examination in experimental animals

Tomoaki Araki, Unit Manager, Safety Assessment Units, SNBL

15:40-16:00

Coffee Break

16:00-17:00

New Paradigm for licensing and partnering -"Drug Candidate Marketplace"-

Hideyuki Hirama, MBA

President &CEO, Gemseki Inc.

 

Haolin Sung, EMBA

Director, Asian Region, Gemseki Inc.

17:00-17:30

Networking